Table 5.

Recommended Surveillance for Individuals with Spastic Paraplegia 3A

System/ConcernEvaluationFrequency
Spasticity Neurologic exam re disease progression & response to current treatment1-2x/yr
Bladder function Per treating urologist, incl monitoring for urinary tract infection
Dysphagia Gastroenterologist / nutrition / feeding team re nutrition & risk for aspiration
Dysarthria Per neurologic assessment & speech/language assessment
Scoliosis General medical exam of musculoskeletal system
Bowel function Per symptoms
Mobility & ADL Rehabilitation medicine, PT, & OT

ADL = activities of daily living; OT = occupational therapist; PT = physical therapist

From: Spastic Paraplegia 3A

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2025.
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2025 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.